ISPOR 2018 BARCELONA – PODSUMOWANIE PREZENTACJI POSTERÓW INSTYTUTU ARCANA
Instytut Arcana pragnie podziękować wszystkim uczestnikom ISPOR 2018 Barcelona, którzy poświęcili czas na spotkanie z nami. Z przyjemnością powitaliśmy nowych i starych znajomych oraz omówiliśmy wspólnie z Wami najnowsze wyzwania i problemy dotyczące zakresu Market Access i opieki zdrowotnej.
Poniżej znajduje się 5 posterów prezentowanych przez Instytutu Arcana podczas ISPOR 2018 Barcelona. Jeśli mają Państwo jakieś pytania dotyczące naszych prac oraz badań, prosimy o kontakt pod adresem: development@inar.pl
HTA MASTER FILE WITH CONTINUOUS MONITORING AND SYNTHESIS OF RELATED DATA – A NEW APPROACHTO INFORMATION MANAGEMENT
BACKGROUND
Consider a global pharmaceutical company which developed a new drug and plans to obtain access to several
markets. In different countries different data need to be gathered and synthesised for the purpose of reimbursement
submission. Moreover, one product might be prescribed for different indications and for each one of them there
might be specific subpopulations with separate evidence related just to them. Another aspect is that, over time, the
clinical evidence may change. Besides, classified information should be protected on different levels. Thus, the
natural aim is to develop a tool that gathers all relevant product-related data in one place and navigates where to
find properly formatted data appropriate for a particular user’s need, e.g. necessary to fulfil local requirements for
reimbursement submission
ANALYSIS OF THE NATIONAL IMPLEMENTATION OF EUNETHTA REA AND FULL ASSESSMENTS
BACKGROUND
In January 2018, a proposal for a regulation of the European Parliament and of the Council on health technology
assessment and amending Directive 2011/24/EU was adopted.1 The proposed regulation aims to strengthen EU
cooperation in terms of joint HTA (health technology assessment). The objective of this analysis is to assess how
current EUnetHTA REAs (Rapid Relative Effectiveness Assessments) have been implemented by national agencies.
Cost-minimisation analysis (CMA) of SQ® HDM SLIT-tablet in patients with house dust mite allergic rhinitis with or without allergic asthma in Poland
BACKGROUND
House dust mites (HDM) are one of the most common sources of indoor allergens around the world
and one of the most common causes of allergic rhinitis (AR) and allergic asthma (AA).
Conventional symptomatic pharmacotherapy is widely used to manage AR and AA, however it does
not adequately control symptoms in some patients. For these patients, allergy immunotherapy (AIT)
should be considered.
Allergy immunotherapy (AIT) is a treatment based on controlled doses of standardised natural or
modified allergens administered as subcutaneous immunotherapy (SCIT) or sublingual
immunotherapy (SLIT-drops or SLIT-tablets).
The SQ® HDM SLIT-tablet has shown efficacy in treating AR and AA in a large clinical trial program.
Cost-utility analysis (CUA) of SQ® HDM SLIT-tablet in patients with house dust mite allergic rhinitis with or without allergic asthma in Poland
BACKGROUND
House dust mites (HDM) are one of the most common sources of indoor allergens around the world
and one of the most common causes of allergic rhinitis (AR) and allergic asthma (AA).
Symptomatic therapy (ST) is often used as the standard of care for the treatment of persistent
moderate-to-severe HDM AR and AA, however it does not adequately control symptoms in some
patients. For these patients, allergy immunotherapy (AIT) should be considered.
The SQ® HDM SLIT-tablet has shown efficacy in treating AR and AA in a large clinical trial program.
REMOVABLE DINOPROSTONE VAGINAL DELIVERY SYSTEM: COST-CONSEQUENCES MODEL FOR CENTRAL AND EASTERN EUROPEAN COUNTRIES
BACKGROUND
The aim of the project was to develop a user-friendly decision model to assess the savings and health benefits of
induction of labour (IOL) when Dinoprostone Vaginal Delivery System (DVDS) is used instead of alternative
technologies in local European practice. The model allowed to reveal changes in time consumed by hospital staff
due to DVDS administration, demonstrate the safety profile of DVDS versus its alternatives and calculate the
total cost of IOL for local settings.
